Mov Disord Vol 31, Suppl 2 Archives - Page 142 of 207 - MDS Abstracts

2016 International Congress
Cardiometabolic syndrome and risk of Parkinson’s disease: A case-control study in Mexican population
G. Parra-López, L. Bazán-Rodríguez, M. Rodríguez-Violante, A. Cervantes-Arriaga, A. Jorge de Saráchaga, M. Escobar-Barrios, E. Carreón-Bautista (Mexico City, Mexico)
Objective: To determine the role of cardiometabolic syndrome such as type 2 diabetes mellitus, hypertension, obesity, dyslipidemia and the risk of developing Parkinson's disease. Background:…
2016 International Congress
The initial motor symptom of Parkinson’s disease in relation to age at onset and gender: A Sri Lankan perspective
V. Suriyakumara, R. Gamage, H. Gunasekara, T. Fernando, A. Jayasuriya, R. Wijeyekoon, T. Muthukuda, R. De Silva (Nugegoda, Sri Lanka)
Objective: To investigate whether the predominant initial PD motor symptom is associated with gender or age of onset of PD in Sri Lanka. Background: Studies…
2016 International Congress
Medication errors: The role of the nurse in an interdisciplinary home visit program for advanced Parkinson’s disease patients
S.E. Oyler, J.E. Fleisher, M.M. Sweeney, A.C. Lemen, A. Fazl, G. Dacpano, R.M. Gilbert, A. Di Rocco, J. Chodosh (New York, NY, USA)
Objective: To examine the number and types of medication errors detected by a registered nurse during interdisciplinary home visits for patients with advanced Parkinson's disease…
2016 International Congress
Impact of subclinical apathy prior to deep brain stimulation on the quality of life of patients with Parkinson’s disease
M.A. Higuchi, T. Mishima, H. Abe, T. Morishita, S. Fujioka, J. Fukae, Y. Tsuboi (Fukuoka, Japan)
Objective: To evaluate the influence of pretreatment subclinical apathy on patient QOL following subthalamic nucleus DBS (STN-DBS) in PD patients 12 months after surgery. Background:…
2016 International Congress
Treating Parkinson’s 2015–A nationwide survey of treatment responses and complications in 1000 Irish patients with Parkinson’s disease
C. Stubbe, P. Bogdanova-Mihaylova, N. Kavanagh, K. Mulpeter, D. Bradley, T. Lynch, T. Counihan, P. Brown, S. O'Sullivan, R.A. Walsh (Dublin, Ireland)
Objective: To collect real-life data from a large cohort with Parkinson's disease (PD), with particular emphasis on drug regimens, motor complications, and quality of life…
2016 International Congress
Measuring interdependence of the health status of people with Parkinson’s disease and their spouses
F. Noubary, S.D. Gunnery, E.M. Naumova, M. Saint-Hilaire, C.A. Thomas, L. Tickle-Degnen (Boston, MA, USA)
Objective: To demonstrate an innovative visualization method for measuring the interdependence of the health status of people with Parkinson's disease (PD) and their spouses over…
2016 International Congress
Prescribed gait tests versus continuous monitoring of gait in people with Parkinson’s disease
C. Curtze, J. McNames, M. El-Gohary, J.G. Nutt, M. Mancini, P. Carlson-Kuhta, F.B. Horak (Portland, OR, USA)
Objective: To determine if prescribed self-administered gait tests are a valid measure of functional everyday mobility in people with idiopathic Parkinson's disease (PD). Background: Motor…
2016 International Congress
Testing feasibility and utility of remote data capture technology to assess Parkinson’s disease
J. Carter, N. Hellmers, A. Hanineva, C. Henchcliffe (New York, NY, USA)
Objective: To test feasibility and utility of home-based video-recording uploaded from a mobile device app to a cloud-based storage platform, in order to quantitate motor…
2016 International Congress
Two new cases of a novel ovario-leukodystrophy related to AARS2 mutation from Korea
H.J. Yang, J.M. Lee, J.H. Kwon, S.T. Lee, H.J. Kim, B. Jeon (Ulsan, Korea)
Objective: Progressive leukoencephalopathy with primary ovarian failure (LKENP; OMIM # 615889) is a novel ovario-leukodystophy caused by compound heterozygote mutations in the AARS2 gene of…
2016 International Congress
Mutational analysis of GNAL gene in isolated dystonia patients from Spain
P. Gómez-Garre, I. Huertas-Fernández, M.T. Cáceres-Redondo, A. Alonso-Canovas, I. Bernal-Bernal, A. Blanco-Ollero, M. Bonilla-Toribio, J.A. Burguera, M. Carballo, F. Carrillo, M.J. Catalán-Alonso, F. Escamilla-Sevilla, R. Espinosa-Rosso, M.C. Fernández-Moreno, J. García-Caldentey, J.M. García-Moreno, S. Giacometti-Silveira, J. Gutiérrez-García, S. Jesús-Maestre, E. López-Valdés, J.C. Martínez-Castrillo, M.P. Medialdea-Natera, C. Méndez-Lucena, A. Mínguez-Castellanos, M. Moya, J.J. Ochoa-Sepúlveda, T. Ojea, N. Rodríguez, I. Rubio-Agusti, M. Sillero-Sánchez, J. del Val, L. Vargas-González, P. Mir (Seville, Spain)
Objective: To study the frequency and spectrum of GNAL genetic variations in a large population of isolated dystonia (DT) patients from Spain. Background: GNAL encodes…